Antibody Drug Conjugates to Treat Cancer A Brief History of Saporin and its Contributions to Neuroscience Targeted Toxins – Cheaper and Quicker than Knockouts A rapid, pH-sensitive screening method to detect internalization of cell surface markers for development of antibody-based pharmaceuticals to treat brain tumors. Screening targeting agents and their cell surface biomarkers for high […]
Visit ATS April 7-10, Booth 3453 to discover how ATS products can advance your Cancer Research Antibody Drug Conjugates to Treat Cancer A Brief History of Saporin and its Contributions to Neuroscience Targeted Toxins – Cheaper and Quicker than Knockouts A rapid, pH-sensitive screening method to detect internalization of cell surface markers for development of
American Association for Cancer Research, AACR 2024 Read More »
Antibody Drug Conjugates to Treat Cancer Antibody Screening for Cancer Research and Drug Development There is a growing need for therapeutics for cancer, autoimmune diseases, blood diseases and Alzheimer’s disease. Due to their ability to bind to a specific target antigen, monoclonal antibodies are increasingly being screened for therapeutic drug development. In May 2021, the
Antibody Drug Conjugates to Treat Cancer Read More »
Also available in Chinese | French | German | Italian | Japanese | Korean | Portuguese | Spanish Leonardo Ancheta, Vice President and Director of Custom Conjugations at ATS, talks about how to make experiments more efficient and more accurate and also lower your costs. keywords: custom conjugation, custom conjugate, custom services, secondary conjugate, direct
Custom Conjugation Service Overview Read More »
Check your Rippy Desk Calendar for the date of the Flash Event!
Flash Calendar Event Coming Soon 2024 Read More »